- Filed
- May 15, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 170.42M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 119.82M sh |
| Capex | Q1 2026 · Mar 31, 2026 | $0 |
| Capex | Q1 2026 · Mar 31, 2025 | $6.19K |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$207.16K |
| Operating Cash Flow restated | Q1 2026 · Mar 31, 2025 | −$392.04K |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $10.38K |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | −$2.3M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | −$1.95M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $3.02M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $2.79M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $3.02M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $2.79M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $597.82K |
| Current Assets | Q1 2026 · Dec 31, 2025 | $667.51K |
| Total Assets | Q1 2026 · Mar 31, 2026 | $709.87K |
| Total Assets | Q1 2026 · Dec 31, 2025 | $847.1K |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | $0.00 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | $0.00 |
| Net Income | Q1 2026 · Mar 31, 2026 | −$272.61K |
| Net Income | Q1 2026 · Mar 31, 2025 | −$435.63K |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$289.27K |
| Operating Income | Q1 2026 · Mar 31, 2025 | −$467.3K |
| Gross Profit | Q1 2026 · Mar 31, 2026 | $0 |
| Gross Profit | Q1 2026 · Mar 31, 2025 | $0 |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $0 |
| Cost Of Revenue | Q1 2026 · Mar 31, 2025 | $0 |
| Revenue | Q1 2026 · Mar 31, 2026 | $0 |
| Revenue | Q1 2026 · Mar 31, 2025 | $0 |